{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T15:44:32Z","timestamp":1777045472797,"version":"3.51.4"},"reference-count":43,"publisher":"Zhejiang University Press","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the National Institutes of Health","award":["R01HL141336"],"award-info":[{"award-number":["R01HL141336"]}]},{"name":"the Margaret E. Early Medical Research Trust Award"},{"name":"the Stop Cancer Research Career Development Award, V Scholar Award of Cancer Research"},{"name":"the Gehr Family Center for Leukemia Research, USA"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Zhejiang Univ. Sci. B"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1631\/jzus.b1900148","type":"journal-article","created":{"date-parts":[[2019,5,16]],"date-time":"2019-05-16T12:04:14Z","timestamp":1558008254000},"page":"391-398","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Role of SIRT1 in hematologic malignancies","SIRT1 \u5728\u8840\u6db2\u7cfb\u7edf\u80bf\u7624\u4e2d\u7684\u7814\u7a76\u8fdb\u5c55"],"prefix":"10.1631","volume":"20","author":[{"given":"Fei-teng","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying-hui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao-jie","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-ying","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7568-939X","authenticated-orcid":false,"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"635","published-online":{"date-parts":[[2019,5,16]]},"reference":[{"issue":"13","key":"352_CR1","doi-asserted-by":"publisher","first-page":"4473","DOI":"10.1158\/0008-5472.CAN-10-4452","volume":"71","author":"V Audrito","year":"2011","unstructured":"Audrito V, Vaisitti T, Rossi D, et al., 2011. Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53\/miR-34a\/SIRT1 tumor suppressor network. Cancer Res, 71(13):4473\u20134483. \n                    https:\/\/doi.org\/10.1158\/0008-5472.can-10-4452","journal-title":"Cancer Res"},{"issue":"3","key":"352_CR2","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1080\/15384047.2016.1139246","volume":"17","author":"S Bhalla","year":"2016","unstructured":"Bhalla S, Gordon LI, 2016. Functional characterization of NAD dependent deacetylases SIRT1 and SIRT2 in B-cell chronic lymphocytic leukemia (CLL). Cancer Biol Ther, 17(3):300\u2013309. \n                    https:\/\/doi.org\/10.1080\/15384047.2016.1139246","journal-title":"Cancer Biol Ther"},{"issue":"6","key":"352_CR3","doi-asserted-by":"publisher","first-page":"e205","DOI":"10.1016\/S1470-2045(12)70580-6","volume":"14","author":"D Bhojwani","year":"2013","unstructured":"Bhojwani D, Pui CH, 2013. Relapsed childhood acute lymphoblastic leukaemia. Lancet Oncol, 14(6):e205\u2013e217. \n                    https:\/\/doi.org\/10.1016\/s1470-2045(12)70580-6","journal-title":"Lancet Oncol"},{"issue":"10","key":"352_CR4","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1038\/sj.leu.2403910","volume":"19","author":"CA Bradbury","year":"2005","unstructured":"Bradbury CA, Khanim FL, Hayden R, et al., 2005. Histone deacetylases in acute myeloid leukaemia show a distinctive pattern of expression that changes selectively in response to deacetylase inhibitors. Leukemia, 19(10):1751\u20131759. \n                    https:\/\/doi.org\/10.1038\/sj.leu.2403910","journal-title":"Leukemia"},{"issue":"2","key":"352_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrc2562","volume":"9","author":"CL Brooks","year":"2009","unstructured":"Brooks CL, Gu W, 2009. How does SIRT1 affect metabolism, senescence and cancer? Nat Rev Cancer, 9(2):123\u2013128. \n                    https:\/\/doi.org\/10.1038\/nrc2562","journal-title":"Nat Rev Cancer"},{"issue":"10","key":"352_CR6","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/nrc3985","volume":"15","author":"A Chalkiadaki","year":"2015","unstructured":"Chalkiadaki A, Guarente L, 2015. The multifaceted functions of sirtuins in cancer. Nat Rev Cancer, 15(10):608\u2013624. \n                    https:\/\/doi.org\/10.1038\/nrc3985","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"352_CR7","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nm.3832","volume":"21","author":"CW Chen","year":"2015","unstructured":"Chen CW, Koche RP, Sinha AU, et al., 2015. DOT1L inhibits SIRT1-mediated epigenetic silencing to maintain leukemic gene expression in MLL-rearranged leukemia. Nat Med, 21(4):335\u2013343. \n                    https:\/\/doi.org\/10.1038\/nm.3832","journal-title":"Nat Med"},{"issue":"3","key":"352_CR8","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1182\/blood-2018-07-863233","volume":"133","author":"A Daenthanasanmak","year":"2019","unstructured":"Daenthanasanmak A, Iamsawat S, Chakraborty P, et al., 2019. Targeting Sirt-1 controls GVHD by inhibiting T-cell alloresponse and promoting Treg stability in mice. Blood, 133(3):266\u2013279. \n                    https:\/\/doi.org\/10.1182\/blood-2018-07-863233","journal-title":"Blood"},{"issue":"22","key":"352_CR9","doi-asserted-by":"publisher","first-page":"19102","DOI":"10.18632\/oncotarget.3905","volume":"6","author":"M dal Bo","year":"2015","unstructured":"dal Bo M, D\u2019Agaro T, Gobessi S, et al., 2015. The SIRT1\/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells. Oncotarget, 6(22):19102\u201319117. \n                    https:\/\/doi.org\/10.18632\/oncotarget.3905","journal-title":"Oncotarget"},{"issue":"3","key":"352_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1002\/path.4905","volume":"242","author":"ML He","year":"2017","unstructured":"He ML, Tan B, Vasan K, et al., 2017. SIRT1 and AMPK pathways are essential for the proliferation and survival of primary effusion lymphoma cells. J Pathol, 242(3):309\u2013321. \n                    https:\/\/doi.org\/10.1002\/path.4905","journal-title":"J Pathol"},{"issue":"8","key":"352_CR11","doi-asserted-by":"publisher","first-page":"4368","DOI":"10.1158\/0008-5472.CAN-05-3617","volume":"66","author":"B Heltweg","year":"2006","unstructured":"Heltweg B, Gatbonton T, Schuler AD, et al., 2006. Antitumor activity of a small-molecule inhibitor of human silent information regulator 2 enzymes. Cancer Res, 66(8): 4368\u20134377. \n                    https:\/\/doi.org\/10.1158\/0008-5472.can-05-3617","journal-title":"Cancer Res"},{"issue":"12","key":"352_CR12","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/nrc2962","volume":"10","author":"D Herranz","year":"2010","unstructured":"Herranz D, Serrano M, 2010. SIRT1: recent lessons from mouse models. Nat Rev Cancer, 10(12):819\u2013823. \n                    https:\/\/doi.org\/10.1038\/nrc2962","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"352_CR13","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.molcel.2014.12.013","volume":"57","author":"R Huang","year":"2015","unstructured":"Huang R, Xu YF, Wan W, et al., 2015. Deacetylation of nuclear LC3 drives autophagy initiation under starvation. Mol Cell, 57(3):456\u2013466. \n                    https:\/\/doi.org\/10.1016\/j.molcel.2014.12.013","journal-title":"Mol Cell"},{"issue":"10","key":"352_CR14","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1097\/PAS.0b013e31816b6478","volume":"32","author":"KY Jang","year":"2008","unstructured":"Jang KY, Hwang SH, Kwon KS, et al., 2008. SIRT1 expression is associated with poor prognosis of diffuse large B-cell lymphoma. Am J Surg Pathol, 32(10):1523\u20131531. \n                    https:\/\/doi.org\/10.1097\/PAS.0b013e31816b6478","journal-title":"Am J Surg Pathol"},{"key":"352_CR15","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12885-015-1282-1","volume":"15","author":"YL Jin","year":"2015","unstructured":"Jin YL, Cao Q, Chen C, et al., 2015. Tenovin-6-mediated inhibition of SIRT1\/2 induces apoptosis in acute lymphoblastic leukemia (ALL) cells and eliminates ALL stem\/progenitor cells. BMC Cancer, 15:226. \n                    https:\/\/doi.org\/10.1186\/s12885-015-1282-1","journal-title":"BMC Cancer"},{"key":"352_CR16","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12935-018-0659-z","volume":"18","author":"YT Kan","year":"2018","unstructured":"Kan YT, Ge P, Wang XY, et al., 2018. SIRT1 rs3758391 polymorphism and risk of diffuse large B cell lymphoma in a Chinese population. Cancer Cell Int, 18:163. \n                    https:\/\/doi.org\/10.1186\/s12935-018-0659-z","journal-title":"Cancer Cell Int"},{"issue":"9","key":"352_CR17","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1073\/pnas.0712145105","volume":"105","author":"IH Lee","year":"2008","unstructured":"Lee IH, Cao L, Mostoslavsky R, et al., 2008. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc Natl Acad Sci USA, 105(9):3374\u20133379. \n                    https:\/\/doi.org\/10.1073\/pnas.0712145105","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"352_CR18","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ccr.2011.12.020","volume":"21","author":"L Li","year":"2012","unstructured":"Li L, Wang LS, Li L, et al., 2012. Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib. Cancer Cell, 21(2): 266\u2013281. \n                    https:\/\/doi.org\/10.1016\/j.ccr.2011.12.020","journal-title":"Cancer Cell"},{"issue":"4","key":"352_CR19","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.stem.2014.08.001","volume":"15","author":"L Li","year":"2014","unstructured":"Li L, Osdal T, Ho Y, et al., 2014. SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells. Cell Stem Cell, 15(4):431\u2013446. \n                    https:\/\/doi.org\/10.1016\/j.stem.2014.08.001","journal-title":"Cell Stem Cell"},{"issue":"6","key":"352_CR20","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.3892\/or.2015.4287","volume":"34","author":"L Li","year":"2015","unstructured":"Li L, Ye SG, Yang M, et al., 2015. SIRT1 downregulation enhances chemosensitivity and survival of adult T-cell leukemia-lymphoma cells by reducing DNA doublestrand repair. Oncol Rep, 34(6):2935\u20132942. \n                    https:\/\/doi.org\/10.3892\/or.2015.4287","journal-title":"Oncol Rep"},{"issue":"2","key":"352_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0092-8674(01)00524-4","volume":"107","author":"JY Luo","year":"2001","unstructured":"Luo JY, Nikolaev AY, Imai SI, et al., 2001. Negative control of p53 by Sir2\u03b1 promotes cell survival under stress. Cell, 107(2):137\u2013148. \n                    https:\/\/doi.org\/10.1016\/S0092-8674(01)00524-4","journal-title":"Cell"},{"issue":"7633","key":"352_CR22","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nature20598","volume":"540","author":"SWK Ng","year":"2016","unstructured":"Ng SWK, Mitchell A, Kennedy JA, et al., 2016. A 17-gene stemness score for rapid determination of risk in acute leukaemia. Nature, 540(7633):433\u2013437. \n                    https:\/\/doi.org\/10.1038\/nature20598","journal-title":"Nature"},{"issue":"4","key":"352_CR23","doi-asserted-by":"publisher","first-page":"632","DOI":"10.4161\/cc.27523","volume":"13","author":"M Nihal","year":"2014","unstructured":"Nihal M, Ahmad N, Wood GS, 2014. SIRT1 is upregulated in cutaneous T-cell lymphoma, and its inhibition induces growth arrest and apoptosis. Cell Cycle, 13(4):632\u2013640. \n                    https:\/\/doi.org\/10.4161\/cc.27523","journal-title":"Cell Cycle"},{"issue":"5","key":"352_CR24","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1002\/stem.1641","volume":"32","author":"X Ou","year":"2014","unstructured":"Ou X, Lee MR, Huang XX, et al., 2014. SIRT1 positively regulates autophagy and mitochondria function in embryonic stem cells under oxidative stress. Stem Cells, 32(5):1183\u20131194. \n                    https:\/\/doi.org\/10.1002\/stem.1641","journal-title":"Stem Cells"},{"issue":"12","key":"352_CR25","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1056\/NEJMoa1112304","volume":"366","author":"JP Patel","year":"2012","unstructured":"Patel JP, G\u00f6nen M, Figueroa ME, et al., 2012. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med, 366(12):1079\u20131089. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1112304","journal-title":"N Engl J Med"},{"issue":"15","key":"352_CR26","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1056\/NEJMra023001","volume":"350","author":"CH Pui","year":"2004","unstructured":"Pui CH, Relling MV, Downing JR, 2004. Mechanisms of disease: acute lymphoblastic leukemia. N Engl J Med, 350(15):1535\u20131548. \n                    https:\/\/doi.org\/10.1056\/NEJMra023001","journal-title":"N Engl J Med"},{"issue":"10","key":"352_CR27","first-page":"13241","volume":"8","author":"AE Quesada","year":"2015","unstructured":"Quesada AE, Assylbekova B, Jabcuga CE, et al., 2015. Expression of Sirt1 and FoxP3 in classical Hodgkin lymphoma and tumor infiltrating lymphocytes: implications for immune dysregulation, prognosis and potential therapeutic targeting. Int J Clin Exp Pathol, 8(10): 13241\u201313248.","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"352_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/bjh.14973","volume":"180","author":"D Rea","year":"2018","unstructured":"Rea D, Mahon FX, 2018. How I manage relapse of chronic myeloid leukaemia after stopping tyrosine kinase inhibitor therapy. Br J Haematol, 180(1):24\u201332. \n                    https:\/\/doi.org\/10.1111\/bjh.14973","journal-title":"Br J Haematol"},{"issue":"3","key":"352_CR29","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nrc1567","volume":"5","author":"RB Ren","year":"2005","unstructured":"Ren RB, 2005. Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer, 5(3): 172\u2013183. \n                    https:\/\/doi.org\/10.1038\/nrc1567","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"352_CR30","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1182\/blood-2013-02-483750","volume":"122","author":"DM Ross","year":"2013","unstructured":"Ross DM, Branford S, Seymour JF, et al., 2013. Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study. Blood, 122(4):515\u2013522. \n                    https:\/\/doi.org\/10.1182\/blood-2013-02-483750","journal-title":"Blood"},{"issue":"31","key":"352_CR31","doi-asserted-by":"publisher","first-page":"50195","DOI":"10.18632\/oncotarget.10328","volume":"7","author":"M Roth","year":"2016","unstructured":"Roth M, Wang ZQ, Chen WY, 2016. SIRT1 and LSD1 competitively regulate KU70 functions in DNA repair and mutation acquisition in cancer cells. Oncotarget, 7(31):50195\u201350214. \n                    https:\/\/doi.org\/10.18632\/oncotarget.10328","journal-title":"Oncotarget"},{"issue":"1","key":"352_CR32","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1182\/blood-2013-11-538819","volume":"124","author":"D Sasca","year":"2014","unstructured":"Sasca D, H\u00e4hnel PS, Szybinski J, et al., 2014. SIRT1 prevents genotoxic stress-induced p53 activation in acute myeloid leukemia. Blood, 124(1):121\u2013133. \n                    https:\/\/doi.org\/10.1182\/blood-2013-11-538819","journal-title":"Blood"},{"issue":"1","key":"352_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrc.2016.112","volume":"17","author":"AS Sperling","year":"2017","unstructured":"Sperling AS, Gibson CJ, Ebert BL, 2017. The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia. Nat Rev Cancer, 17(1):5\u201319. \n                    https:\/\/doi.org\/10.1038\/nrc.2016.112","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"352_CR34","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.stem.2018.07.018","volume":"23","author":"J Sun","year":"2018","unstructured":"Sun J, He X, Zhu YH, et al., 2018. SIRT1 activation disrupts maintenance of myelodysplastic syndrome stem and progenitor cells by restoring TET2 function. Cell Stem Cell, 23(3):355\u2013369.e9. \n                    https:\/\/doi.org\/10.1016\/j.stem.2018.07.018","journal-title":"Cell Stem Cell"},{"issue":"2","key":"352_CR35","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.yexcr.2018.02.036","volume":"365","author":"WL Tian","year":"2018","unstructured":"Tian WL, Guo R, Wang F, et al., 2018. The IRF9-SIRT1-P53 axis is involved in the growth of human acute myeloid leukemia. Exp Cell Res, 365(2):185\u2013193. \n                    https:\/\/doi.org\/10.1016\/j.yexcr.2018.02.036","journal-title":"Exp Cell Res"},{"issue":"2","key":"352_CR36","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0092-8674(01)00527-X","volume":"107","author":"H Vaziri","year":"2001","unstructured":"Vaziri H, Dessain SK, Ng Eaton E, et al., 2001. hSIR2\n                           SIRT1 functions as an NAD-dependent p53 deacetylase. Cell, 107(2):149\u2013159. \n                    https:\/\/doi.org\/10.1016\/S0092-8674(01)00527-X","journal-title":"Cell"},{"issue":"9","key":"352_CR37","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/ncb1468","volume":"8","author":"CG Wang","year":"2006","unstructured":"Wang CG, Chen LH, Hou XH, et al., 2006. Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage. Nat Cell Biol, 8(9):1025\u20131031. \n                    https:\/\/doi.org\/10.1038\/ncb1468","journal-title":"Nat Cell Biol"},{"issue":"4","key":"352_CR38","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.ccr.2008.09.001","volume":"14","author":"RH Wang","year":"2008","unstructured":"Wang RH, Sengupta K, Li CL, et al., 2008. Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell, 14(4):312\u2013323. \n                    https:\/\/doi.org\/10.1016\/j.ccr.2008.09.001","journal-title":"Cancer Cell"},{"issue":"5","key":"352_CR39","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/onc.2012.83","volume":"32","author":"Z Wang","year":"2013","unstructured":"Wang Z, Yuan H, Roth M, et al., 2013. SIRT1 deacetylase promotes acquisition of genetic mutations for drug resistance in CML cells. Oncogene, 32(5):589\u2013598. \n                    https:\/\/doi.org\/10.1038\/onc.2012.83","journal-title":"Oncogene"},{"issue":"12","key":"352_CR40","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1002\/stem.2218","volume":"33","author":"ZQ Wang","year":"2015","unstructured":"Wang ZQ, Chen CC, Chen WY, 2015. CD150\u2212 side population defines leukemia stem cells in a BALB\/c mouse model of CML and is depleted by genetic loss of SIRT1. Stem Cells, 33(12):3437\u20133451. \n                    https:\/\/doi.org\/10.1002\/stem.2218","journal-title":"Stem Cells"},{"issue":"8","key":"352_CR41","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1182\/blood-2011-06-361691","volume":"119","author":"HF Yuan","year":"2012","unstructured":"Yuan HF, Wang ZQ, Li L, et al., 2012. Activation of stress response gene SIRT1 by BCR-ABL promotes leukemogenesis. Blood, 119(8):1904\u20131914. \n                    https:\/\/doi.org\/10.1182\/blood-2011-06-361691","journal-title":"Blood"},{"issue":"9","key":"352_CR42","doi-asserted-by":"crossref","first-page":"14912","DOI":"10.18632\/oncotarget.14741","volume":"8","author":"HF Yuan","year":"2017","unstructured":"Yuan HF, He ML, Cheng F, et al., 2017. Tenovin-6 inhibits proliferation and survival of diffuse large B-cell lymphoma cells by blocking autophagy. Oncotarget, 8(9): 14912\u201314924. \n                    https:\/\/doi.org\/10.18632\/oncotarget.14741","journal-title":"Oncotarget"},{"issue":"12","key":"352_CR43","doi-asserted-by":"crossref","first-page":"13538","DOI":"10.18632\/oncotarget.6455","volume":"7","author":"WJ Zhang","year":"2016","unstructured":"Zhang WJ, Wu HX, Yang M, et al., 2016. SIRT1 inhibition impairs non-homologous end joining DNA damage repair by increasing Ku70 acetylation in chronic myeloid leukemia cells. Oncotarget, 7(12):13538\u201313550. \n                    https:\/\/doi.org\/10.18632\/oncotarget.6455","journal-title":"Oncotarget"}],"container-title":["Journal of Zhejiang University-SCIENCE B"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B1900148.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1631\/jzus.B1900148\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1631\/jzus.B1900148.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T23:08:45Z","timestamp":1589497725000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1631\/jzus.B1900148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["352"],"URL":"https:\/\/doi.org\/10.1631\/jzus.b1900148","relation":{},"ISSN":["1673-1581","1862-1783"],"issn-type":[{"value":"1673-1581","type":"print"},{"value":"1862-1783","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"24 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}